CVR: 45253295
DKK -44,590,096
Gross profit
Net result: DKK -39,672,013
Novo Holdings A/S, Demetrios Thomas Braddock
4 more
CVR · view ownership and management
Owner registered: Novo Holdings A/S
CVR · 17/08/2026
View the full event history
RheumaLogics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Sylvester Skjærbæk. The company's owners include Novo Holdings A/S, Demetrios Thomas Braddock and F-Prime Capital Partners Life Sciences Fund IX LP. In 2025, the company reported a gross profit of DKK -44,590,096 and a net result of DKK -39,672,013. Equity in the 2025 report amounted to DKK 22,357,721.
Selskabets formål er forskning, udvikling og kommercialisering af medicinske produkter samt aktiviteter, der efter bestyrelsens skøn er forbundet dermed.
Source: annual reports filed with the Danish Business Authority.
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorRheumaLogics ApS was founded on 5 December 2024.
RheumaLogics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
The owners of RheumaLogics ApS include Novo Holdings A/S, Demetrios Thomas Braddock and F-Prime Capital Partners Life Sciences Fund IX LP.
In 2025, RheumaLogics ApS reported a gross profit of DKK -44,590,096.
The management of RheumaLogics ApS consists of Søren Sylvester Skjærbæk.
RheumaLogics ApS is located at c/o Symbion, Fruebjergvej 3, 2100 København Ø.
Claim this page to add your logo and social links. Free to get started.
As of August 17, 2026, Novo Holdings A/S is registered as an owner of RheumaLogics ApS with an ownership share of 33%.
As of August 17, 2026, is registered as an owner of RheumaLogics ApS with an ownership share of 5%.
As of August 17, 2026, is registered as an owner of RheumaLogics ApS with an ownership share of 10%.
As of August 17, 2026, is registered as an owner of RheumaLogics ApS with an ownership share of 10%.
As of August 17, 2026, is registered as an owner of RheumaLogics ApS with an ownership share of 10%.
As of August 17, 2026, is registered as an owner of RheumaLogics ApS with an ownership share of 5%.
As of July 10, 2026, Gabor Gyulveszi has joined the board of directors of RheumaLogics ApS.
As of July 10, 2026, Alex Thomas Pasteur has joined the board of directors of RheumaLogics ApS.
As of July 10, 2026, Balaji Muralidhar has joined the board of directors of RheumaLogics ApS.
As of July 10, 2026, Megan Shea Lipcsey has joined the board of directors of RheumaLogics ApS.
As of July 10, 2026, Marianne Uteng has joined the board of directors of RheumaLogics ApS.
As of July 10, 2026, Reinaldo Miguel Diaz has left the board of directors of RheumaLogics ApS.
RheumaLogics ApS has published its annual report for 2025. Gross profit came to DKK -44,590,096, and the net result was DKK -39,672,013.
As of June 22, 2026, Søren Sylvester Skjærbæk is registered as director of RheumaLogics ApS.
As of June 22, 2026, Jørgen Søberg Petersen has stepped down as director of RheumaLogics ApS.
As of December 5, 2024, EY Godkendt Revisionspartnerselskab has been appointed auditor of RheumaLogics ApS.
As of December 5, 2024, Jørgen Søberg Petersen has joined the board of directors of RheumaLogics ApS.
As of December 5, 2024, Reinaldo Miguel Diaz has joined the board of directors of RheumaLogics ApS.
As of December 5, 2024, Jørgen Søberg Petersen is registered as director of RheumaLogics ApS.
RheumaLogics ApS was founded on December 5, 2024.
Companies in the same industry and area
CVR 39330784
CVR 26333210
CVR 26392861
CVR 41366044
CVR 27701396
